07:00 ETAvere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001prnewswire·Aug 10 at 06:05 AMNXTC-4.57%
The Market's Island of Misfit Toys: Real Cash, Fake Hype, and SPAC ZombiesGlobal Report·Aug 9 at 04:12 AMCTAS-1.03%IFF-1.20%
Beyond the Hardware: How Wix and Mid-Cap Techs Are Rewriting the AI PlaybookGlobal Report·Aug 8 at 04:20 AMDOCU-3.06%WIX-1.21%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Aug 7 at 04:05 PMABCL-2.42%NXTC-4.57%
The Island of Misfit Stocks: From Nestle's Fire Sale to Micro-Cap MergersGlobal Report·Aug 7 at 04:18 AMJMHLY-0.38%NSRGY-2.39%
Beyond the Macro Noise: 10 Under-the-Radar Strategic Shifts This WeekGlobal Report·Aug 6 at 04:15 AMWTW-0.75%HCA+0.06%
ADAR1 Capital Management reports NextCure common share purchase worth $3.59 millionPUBT·Aug 3 at 04:53 PMNXTC-4.57%
Corporate Disclosures Highlight Divergence as AI Infrastructure and Energy Outpace Legacy SectorsGlobal Report·Jul 30 at 04:14 AMFANG+0.22%FRMI-2.27%
NextCure files Form 3 initial beneficial ownership statement for ADAR1 Capital ManagementPUBT·Jul 29 at 05:04 PMNXTC-4.57%
